Lex
Start free scan
Lex/EU lobbying/Novo Nordisk A/S
Organisation · Transparency Register · 29570313329-11

Novo Nordisk A/S

EU lobbying footprint — who they meet, and on what. Built only from official disclosures, every meeting cited.

Disclosed meetings78 (17 EC · 61 EP)
Register no.29570313329-11
Period2024-07-16 → 2026-07-03
In short

Novo Nordisk A/S has 78 disclosed EU lobbying meetings from 2024-07-16 to 2026-07-03: 17 with the European Commission and 61 with Members of the European Parliament. Source: EU Transparency Register no. 29570313329-11, Commission disclosures and MEP declarations.

Does Novo Nordisk A/S lobby on the files that affect you?
Run a free exposure scan — see where your company overlaps with this footprint, ranked across the EU corpus.
Scan my company →Ask Lex about Novo Nordisk A/S

Lobbying profile

as declared 2026-03-13
Category
Companies & groups
Legal status
Corporation
Declared lobbying cost
€2,000,000
Lobbying FTEs
3.55
Members
6
LobbyFacts / Transparency Register source ↗

Files it’s lobbying on

The org's disclosed policy areas, ranked by number of meetings.

Technology4 mtgs
Finance4 mtgs
Trade1 mtgs
Health1 mtgs
Industry1 mtgs
A disclosed meeting is contact, not influence. Counts are of disclosed meetings only.

Declared fields of interest

Business and industry · Climate action · Digital economy and society · Energy · Environment · Public health · Research and innovation · Trade

At a glance

The officials and MEPs most often met, by disclosed-meeting count.

Commission officials
  • Andreas Schwarz3
  • Dan Jørgensen1
  • Roxana Mînzatu1
  • Ekaterina Zaharieva1
  • Matthias Jorgensen1

Disclosed meetings

Newest first, showing the most recent 60 of 78. EC = European Commission, EP = Member of the European Parliament.

Frequently asked

How many EU lobbying meetings has Novo Nordisk A/S disclosed?

Novo Nordisk A/S (EU Transparency Register no. 29570313329-11) appears in 78 disclosed meetings with EU officials and MEPs between 2024-07-16 and 2026-07-03: 17 with the European Commission and 61 with Members of the European Parliament.

What does Novo Nordisk A/S lobby on?

Novo Nordisk A/S's disclosed EU meetings most often concern Technology, Finance, Trade, Health. Every meeting and its topic is listed with its official source on this page.

Who does Novo Nordisk A/S meet in Brussels?

Across its disclosed meetings, Novo Nordisk A/S has met Commission officials including Andreas Schwarz, Dan Jørgensen, Roxana Mînzatu, and MEPs including HANSEN Niels Flemming, SOKOL Tomislav, BOSSE Stine. These are counts of officially disclosed meetings, not a measure of influence.

Primary sources

EU Transparency Register · no. 29570313329-11 ↗European Commission meeting disclosures ↗European Parliament — MEP meeting declarations ↗

Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.

Related on the graph

The same footprint, mapped onto the topics and files it touches.

Topic
Who lobbies on Technology & Digital
The organisations meeting MEPs on this area
Topic
Who lobbies on Banking & Capital Markets
The organisations meeting MEPs on this area
Topic
Who lobbies on Healthcare & Medical Devices
The organisations meeting MEPs on this area
Topic
Who lobbies on Manufacturing & Industrial
The organisations meeting MEPs on this area

Get the EU lobbying brief

We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.

See your company’s overlap with Novo Nordisk A/S — and the rest of the corpus.

Enter your company and Lex builds a cited Exposure Map in about 30 seconds. Free, no login.

Map my exposure — freeAsk Lex about Novo Nordisk A/S